Spyros Papapetropoulos - Apr 16, 2025 Form 4 Insider Report for Neuphoria Therapeutics Inc. (NEUP)

Role
President and CEO, Director
Signature
/s/ Elaine Wangsawidjaja, Attorney-in-Fact for Spyros Papapetropoulos
Stock symbol
NEUP
Transactions as of
Apr 16, 2025
Transactions value $
$1,393,200
Form type
4
Date filed
4/18/2025, 08:04 AM
Previous filing
Jul 8, 2024
Next filing
Jun 5, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUP Employee Stock Option (Right-to-Buy) Award $1.39M +270K +2155% $5.16 283K Apr 16, 2025 Common Stock 270K $5.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person's continuing service with the Company, the options shall vest on a monthly basis over a three-year period at the rate of 2.78% of the shares of Common Stock on the last day of each month following September 1, 2024 until the options are vested.